Clinical Implications and Economic Impact of Accuracy Differences among Commercially Available Blood Glucose Monitoring Systems
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background: Despite accuracy standards, there are performance differences among commercially available blood glucose monitoring (BGM) systems. The objective of this analysis was to assess the potential clinical and economic impact of accuracy differences of various BGM systems using a modeling approach. Methods: We simulated additional risk of hypoglycemia due to blood glucose (BG) measurement errors of five different BGM systems based on results of a real-world accuracy study, while retaining other sources of glycemic variability. Using data from published literature, we estimated an annual additional number of required medical interventions as a result of hypoglycemia. We based our calculations on patients with type 1 diabetes mellitus (T1DM) and T2DM requiring multiple daily injections (MDIs) of insulin in a U.S. health care system. We estimated additional costs attributable to treatment of severe hypoglycemic episodes resulting from BG measurement errors. Results: Results from our model predict an annual difference of approximately 296,000 severe hypoglycemic episodes from BG measurement errors for T1DM (105,000 for T2DM MDI) patients for the estimated U.S. population of 958,800 T1DM and 1,353,600 T2DM MDI patients, using the least accurate BGM system versus patients using the most accurate system in a U.S. health care system. This resulted in additional direct costs of approximately $339 million for T1DM and approximately $121 million for T2DM MDI patients per year. Conclusion: Our analysis shows that error patterns over the operating range of BGM meter may lead to relevant clinical and economic outcome differences that may not be reflected in a common accuracy metric or standard. Further research is necessary to validate the findings of this model-based approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640
Hypoglycaemia in Type 2 diabetes
Amiel, S. A., Dixon, T., Mann, R., & Jameson, K. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02341.x · Cited by 472
Freckmann, G., Schmid, C., Baumstark, A., Pleus, S., Link, M., & Haug, C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600510 · Cited by 237
System Accuracy Evaluation of 27 Blood Glucose Monitoring Systems According to DIN EN ISO 15197
Freckmann, G., Baumstark, A., Jendrike, N., Zschornack, E., Kocher, S., Tshiananga, J., Heister, F., & Haug, C. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0128 · Cited by 195
Schopman, J. E., Geddes, J., & Frier, B. M. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.013 · Cited by 150
Research works printed but not linked: 19
- 10.1177/193229680900300438 · DOI · Paper page
- International Organization for Standardization, 2003, In vitro diagnostic test systems – requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus
- International Organization for Standardization, 2011, In vitro diagnostic test systems – requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus
- Curkendall SM, 2011, J Clin Outcomes Manage., 18, 455
- 10.2337/dc11-S011 · DOI · Paper page
- 10.1111/j.1464-5491.2010.03006.x · DOI · Paper page
- Bode B, 2008, Manag Care., 17, 40
- 10.1089/dia.2011.0170 · DOI · Paper page
- 10.1177/193229681100500425 · DOI
- 10.1089/dia.2008.0034 · DOI · Paper page
- Wolpert H., 2002, Smart pumping
- Walsh J, 2006, Pumping insulin: Everything in a book for successful use of an insulin pump
- Centers for Disease Control and Prevention, 2011, National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011
- 10.1177/193229680700100305 · DOI
- Hovorka R, 1993, Am J Physiol., 265, E162
- 10.1016/j.metabol.2004.05.014 · DOI
- 10.1177/193229680800200127 · DOI · Paper page
- 10.2337/dc06-1602 · DOI · Paper page
- 10.1007/978-1-4899-4541-9 · DOI · Paper page
Cited by
Interferences and Limitations in Blood Glucose Self-Testing: An Overview of the Current Knowledge
Erbach, M., Freckmann, G., Hinzmann, R., Kulzer, B., Ziegler, R., Heinemann, L., & Schnell, O. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816641433 · Cited by 115
Performance of Cleared Blood Glucose Monitors
Klonoff, D. C., & Prahalad, P. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815584797 · Cited by 59
Klaff, L. J., Brazg, R., Hughes, K., Tideman, A. M., Schachner, H. C., Stenger, P., Pardo, S., Dunne, N., & Parkes, J. L. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0069 · Cited by 46
A review of blood glucose monitor accuracy
King, F., Ahn, D., Hsiao, V., Porco, T., & Klonoff, D. C. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0232 · Cited by 37
“78 ,79 Finally, as technology continues to advance with the increasing adoption of continuous glucose monitors (CGMs) and closed-loop systems approaching on the horizon, BGM accuracy is more important than ever.”
Boettcher, C., Dost, A., Wudy, S. A., Flechtner-Mors, M., Borkenstein, M., Schiel, R., Weitzel, D., Bechtold-Dalla Pozza, S., Wolf, J., Holl, R. W., et al. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0262 · Cited by 35
Metadata
- Authors
- Budiman, E. S., Samant, N., & Resch, A.
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2013-03
- Volume
- 7
- Issue
- 2
- Pages
- 365-380
- ISSN
- 1932-2968 (ISSN-L)
- OpenAlex
- W1963962528
- Cited by
- 30
- References
- 5
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Implications and Economic Impact of Accuracy Differences among Commercially Available Blood Glucose Monitoring Systems. https://app.cochat.ai/papers/10.1177/193229681300700213
- The paper
- Budiman, E. S., Samant, N., & Resch, A. (2013). Clinical Implications and Economic Impact of Accuracy Differences among Commercially Available Blood Glucose Monitoring Systems. Journal of Diabetes Science and Technology. https://doi.org/10.1177/193229681300700213
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.